Hypertrophic cardiomyopathy requires multidisciplinary care at expert referral centers, and further research is needed to refine sudden cardiac death risk stratification.
Hypertrophic cardiomyopathy (HCM) is a complex cardiovascular disease with wide phenotypic variations. Despite significant advances in imaging and genetic testing, more information is needed about the roles and implications of these resources in clinical practice. Patients with suspected or established HCM should be evaluated at an expert referral center to allow for the best multidisciplinary care. Research is needed to better predict the risk of sudden cardiac death in those judged to be at low risk by current risk-stratification methods.
Young et al. (Tue,) studied this question.